Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

2.0K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

723
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
723
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

119
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

6.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.9K
Lipid Catabolism01:25

Lipid Catabolism

1.4K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coronary artery disease management and cost implications with fractional flow reserve guided coronary intervention in Indian patients with stable ischemic coronary artery disease.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2020
Same author

Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis.

Circulation. Cardiovascular interventions·2018
Same author

Transjugular balloon mitral valvotomy in a patient with severe kyphoscoliosis.

Indian heart journal·2016
Same author

Pseudoaneurysm following transradial coronary angiogram.

European heart journal·2015
Same author

Smoked out!

European heart journal·2015
Same author

Mammoth right atrium.

Journal of the American College of Cardiology·2014
Same journal

Do we need a pediatric cardiac critical care registry in India?

Annals of pediatric cardiology·2026
Same journal

Prenatal therapy of everolimus for large fetal cardiac rhabdomyoma in tuberous sclerosis.

Annals of pediatric cardiology·2026
Same journal

Non-surgical management of post-Ross left ventricular pseudoaneurysm assisted by virtual reality imaging.

Annals of pediatric cardiology·2026
Same journal

Double trouble in tetralogy: Rare sequential pseudoaneurysms managed by distinct surgical and endovascular approaches.

Annals of pediatric cardiology·2026
Same journal

Emerging therapeutic strategies for the failing Fontan circulation.

Annals of pediatric cardiology·2026
Same journal

A randomized controlled trial of electrical cardiometry-guided perioperative hemodynamic management in children undergoing cardiac surgery.

Annals of pediatric cardiology·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

7.5K

Familial hypercholesterolemia: A review.

Mithun J Varghese1

  • 1Department of Cardiology, Christian Medical College, Vellore, Tamil Nadu, India.

Annals of Pediatric Cardiology
|July 3, 2014
PubMed
Summary
This summary is machine-generated.

Familial hypercholesterolemia (FH) is a genetic disorder causing high LDL cholesterol. Early diagnosis and treatment, including statins and newer therapies, are crucial for preventing premature cardiovascular disease, though challenges remain in pediatric management.

Keywords:
Familial hypercholesterolemiaheterozygous familial hypercholesterolemiahomozygous familial hypercholesterolemialow-density lipoprotein receptor mutation

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K
Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

29.4K

Related Experiment Videos

Last Updated: Apr 27, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

7.5K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K
Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

29.4K

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Metabolic Disorders

Background:

  • Familial hypercholesterolemia (FH) is an inherited disorder of lipoprotein metabolism.
  • It leads to significantly elevated serum low-density lipoprotein (LDL) cholesterol levels.
  • This elevates the risk of premature cardiovascular diseases (CVDs).

Purpose of the Study:

  • To review screening, diagnosis, and management strategies for FH.
  • To highlight challenges in achieving lipid goals, particularly in children.
  • To discuss current and emerging treatment options for FH patients.

Main Methods:

  • Review of current literature on FH diagnosis and treatment.
  • Analysis of clinical guidelines and therapeutic approaches.
  • Discussion of genetic testing's role in diagnosis.

Main Results:

  • Diagnosis relies on clinical features, family history, and LDL-cholesterol levels, enhanced by genetic testing.
  • Statins are the primary treatment, supplemented by newer drugs and LDL apheresis for difficult cases.
  • Despite advances, many children with FH do not reach lipid targets due to diagnostic and treatment gaps.

Conclusions:

  • Early identification and intervention are critical for managing FH and reducing CVD risk.
  • While treatments have improved prognosis, especially for heterozygous FH, persistent challenges in pediatric care require attention.
  • Comprehensive management strategies are essential for optimizing outcomes in all FH patients.